These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 19271151

  • 1. Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice.
    Tsai WC, Hershenson MB, Zhou Y, Sajjan U.
    Inflamm Res; 2009 Aug; 58(8):491-501. PubMed ID: 19271151
    [Abstract] [Full Text] [Related]

  • 2. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
    Li Y, Huang J, Li L, Liu L.
    Cell Physiol Biochem; 2017 Aug; 42(4):1657-1669. PubMed ID: 28738346
    [Abstract] [Full Text] [Related]

  • 3. Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.
    Hoffmann N, Lee B, Hentzer M, Rasmussen TB, Song Z, Johansen HK, Givskov M, Høiby N.
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3677-87. PubMed ID: 17620382
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis.
    Wilms EB, Touw DJ, Heijerman HG.
    Ther Drug Monit; 2006 Apr; 28(2):219-25. PubMed ID: 16628134
    [Abstract] [Full Text] [Related]

  • 5. Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells.
    Bergamini G, Cigana C, Sorio C, Della Peruta M, Pompella A, Corti A, Huaux FA, Leal T, Assael BM, Melotti P.
    Am J Respir Cell Mol Biol; 2009 Aug; 41(2):199-206. PubMed ID: 19097986
    [Abstract] [Full Text] [Related]

  • 6. Azithromycin Augments Bacterial Uptake and Anti-Inflammatory Macrophage Polarization in Cystic Fibrosis.
    Tarique AA, Tuladhar N, Kelk D, Begum N, Lucas RM, Luo L, Stow JL, Wainwright CE, Bell SC, Sly PD, Fantino E.
    Cells; 2024 Jan 16; 13(2):. PubMed ID: 38247856
    [Abstract] [Full Text] [Related]

  • 7. Long term azithromycin therapy in patients with cystic fibrosis.
    Emiralioğlu N, Öztürk Z, Yalçın E, Doğru D, Özçelik U, Kiper N.
    Turk J Pediatr; 2016 Jan 16; 58(1):34-40. PubMed ID: 27922234
    [Abstract] [Full Text] [Related]

  • 8. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection.
    Van Heeckeren AM, Scaria A, Schluchter MD, Ferkol TW, Wadsworth S, Davis PB.
    Am J Physiol Lung Cell Mol Physiol; 2004 Apr 16; 286(4):L717-26. PubMed ID: 14514520
    [Abstract] [Full Text] [Related]

  • 9. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.
    Wolter J, Seeney S, Bell S, Bowler S, Masel P, McCormack J.
    Thorax; 2002 Mar 16; 57(3):212-6. PubMed ID: 11867823
    [Abstract] [Full Text] [Related]

  • 10. Buccal adherence of Pseudomonas aeruginosa in patients with cystic fibrosis under long-term therapy with azithromycin.
    Baumann U, Fischer JJ, Gudowius P, Lingner M, Herrmann S, Tümmler B, von der Hardt H.
    Infection; 2001 Mar 16; 29(1):7-11. PubMed ID: 11261763
    [Abstract] [Full Text] [Related]

  • 11. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.
    Steinkamp G, Schmitt-Grohe S, Döring G, Staab D, Pfründer D, Beck G, Schubert R, Zielen S.
    Respir Med; 2008 Nov 16; 102(11):1643-53. PubMed ID: 18701270
    [Abstract] [Full Text] [Related]

  • 12. Azithromycin attenuates pulmonary inflammation and emphysema in smoking-induced COPD model in rats.
    Wan YF, Huang ZH, Jing K, Li J, Wang Y, Xu CQ, Chen JH, Zheng YL.
    Respir Care; 2015 Jan 16; 60(1):128-34. PubMed ID: 25249648
    [Abstract] [Full Text] [Related]

  • 13. Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii.
    Yamada K, Yanagihara K, Kaku N, Harada Y, Migiyama Y, Nagaoka K, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Hasegawa H, Mikamo H, Kohno S.
    Antimicrob Agents Chemother; 2013 Aug 16; 57(8):3883-8. PubMed ID: 23733468
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
    Bensman TJ, Jayne JG, Sun M, Kimura E, Meinert J, Wang JC, Schaal JB, Tran D, Rao AP, Akbari O, Selsted ME, Beringer PM.
    Antimicrob Agents Chemother; 2017 Aug 16; 61(8):. PubMed ID: 28559270
    [Abstract] [Full Text] [Related]

  • 15. Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection.
    Song Z, Wu H, Ciofu O, Kong KF, Høiby N, Rygaard J, Kharazmi A, Mathee K.
    J Med Microbiol; 2003 Sep 16; 52(Pt 9):731-740. PubMed ID: 12909647
    [Abstract] [Full Text] [Related]

  • 16. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.
    Nguyen D, Emond MJ, Mayer-Hamblett N, Saiman L, Marshall BC, Burns JL.
    Pediatr Pulmonol; 2007 Jun 16; 42(6):533-41. PubMed ID: 17469154
    [Abstract] [Full Text] [Related]

  • 17. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.
    Wang Y, Cela E, Gagnon S, Sweezey NB.
    Respir Res; 2010 Nov 30; 11(1):166. PubMed ID: 21118573
    [Abstract] [Full Text] [Related]

  • 18. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic Fibrosis.
    Marteyn BS, Burgel PR, Meijer L, Witko-Sarsat V.
    Front Cell Infect Microbiol; 2017 Nov 30; 7():243. PubMed ID: 28713772
    [Abstract] [Full Text] [Related]

  • 19. Scnn1b-Transgenic BALB/c Mice as a Model of Pseudomonas aeruginosa Infections of the Cystic Fibrosis Lung.
    Brao KJ, Wille BP, Lieberman J, Ernst RK, Shirtliff ME, Harro JM.
    Infect Immun; 2020 Aug 19; 88(9):. PubMed ID: 32631918
    [Abstract] [Full Text] [Related]

  • 20. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.
    Thomsen K, Christophersen L, Lerche CJ, Holmgaard DB, Calum H, Høiby N, Moser C.
    Int J Antimicrob Agents; 2021 Jan 19; 57(1):106213. PubMed ID: 33256950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.